ASX:NXS Next Science (NXS) Stock Price, News & Analysis → Biden’s Sneaky H.R. 5376 Is A Nightmare For Retirement Savers (From Birch Gold) (Ad) Free NXS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume86,564 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Next Science alerts: Email Address Ad Birch GoldBiden’s Sneaky H.R. 5376 Is A Nightmare For Retirement SaversFirst Obamacare For Health, Now Bidencare For 401(k)s - How To Optout>> Request Your FREE Info Kit << About Next Science Stock (ASX:NXS)Next Science Limited engages in the research, development, and commercialization of technologies that address the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial gel that conforms to the postoperative wound; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Sydney, Australia.Read More Ad Birch GoldBiden’s Sneaky H.R. 5376 Is A Nightmare For Retirement SaversFirst Obamacare For Health, Now Bidencare For 401(k)s - How To Optout>> Request Your FREE Info Kit << NXS Stock News HeadlinesApril 28, 2024 | msn.comMidland College revives “Science Extravaganza”April 12, 2024 | msn.comNASA Prepares to Test Next-Gen Solar Sail TechnologyMay 7, 2024 | Birch Gold (Ad)The Sneaky IRS Tax Law that's Sweeping the U.S.In the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.April 8, 2024 | msn.comASX Health Stocks: Patrys and Next Science jump after presenting data on studiesApril 8, 2024 | reuters.comTotal solar eclipse 2024: When is it and what to expect?March 28, 2024 | tmcnet.comNASA Awards Promote Science, Technology, Engineering, Math NationwideMarch 26, 2024 | yahoo.comScience Museum: New gallery about future energy opensMarch 21, 2024 | msn.comNSU hosts regional high school science fairMay 7, 2024 | Birch Gold (Ad)The Sneaky IRS Tax Law that's Sweeping the U.S.In the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.March 20, 2024 | msn.comBusinesses partner with Cambridge Science Centre to increase access to STEM educationMarch 19, 2024 | msn.comSamsung builds lab to research next-gen AI chips; SK Hynix starts mass production of new chipMarch 18, 2024 | marketwatch.comScience Applications Shares Down After 4Q Adj. EPS MissMarch 18, 2024 | yahoo.comNow’s Your Chance To Play HoYoverse’s Next Game Ahead Of LaunchMarch 8, 2024 | msn.comNatural World And AI Take Top Honors at Middle School Science FairMarch 4, 2024 | finance.yahoo.comNext Science Full Year 2023 Earnings: US$0.069 loss per share (vs US$0.06 loss in FY 2022)March 1, 2024 | yahoo.comStudents in Monroe County celebrate Science DayMarch 1, 2024 | yahoo.comShure's MXW neXt 2 Now Certified for Microsoft TeamsFebruary 29, 2024 | finance.yahoo.comWill Next Science (ASX:NXS) Spend Its Cash Wisely?February 9, 2024 | yahoo.comThe onX Effect: Digital Mapping Apps Have Changed the Way We Hunt. Now What Will They Do With All Our Data?January 26, 2024 | yahoo.comFiber Innovators Explore Next-Gen Silk, Inditex Debuts Jacket Made From Textile WasteJanuary 10, 2024 | morningstar.comNext Science Ltd NXSJanuary 4, 2024 | yahoo.comThe 10 Science Moments You Need to Care About in 2024November 14, 2023 | msn.com'High school dropouts can still be successful'October 31, 2023 | businesswire.comNexthink Commits to reach a Net-Zero Standard by 2050October 13, 2023 | msn.comA scientist may have just proven that we all live inside a computer simulationOctober 11, 2023 | msn.comMoment of Science: EclipsesOctober 1, 2023 | msn.comDr Boreham’s Crucible: With a US focus, can Next Science’s new leaders stem the bleeding?See More Headlines Receive NXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Next Science and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:NXS CUSIPN/A CIKN/A Webwww.nextscience.com Phone61 2 8607 5124FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,270,000.00 Net Margins-73.36% Pretax MarginN/A Return on Equity-156.02% Return on Assets-65.58% Debt Debt-to-Equity Ratio7.50 Current Ratio3.64 Quick Ratio4.80 Sales & Book Value Annual Sales$22.18 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow17.23 Book ValueA$0.04 per share Price / BookN/AMiscellaneous Outstanding Shares291,700,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.04 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Harry Thomas HallMD, CEO & DirectorDr. Matthew Franco MynttiFounder & CTOMarc ZimmermanChief Financial OfficerMr. Jon SwansonChief Operating OfficerMr. Robert BellSenior Vice President of North American SalesMs. Gillian Maria Nairn AGIAB.A., BA, L.L.B., L.L.M., LLB, LLM, MAICD, Company SecretaryMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All CompetitorsInsidersHarry Hall(IV)Sold 200,000 sharesTotal: $54,400.00 ($0.27/share)Judith MitchellSold 420,000 sharesTotal: $220,500.00 ($0.53/share) NXS Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Next Science own? Based on aggregate information from My MarketBeat watchlists, some companies that other Next Science investors own include Abbott Laboratories (ABT), AbbVie (ABBV), Goldman Sachs Physical Gold ETF (AAAU), Argo Investments (ARG), Arcturus Therapeutics (ARCT), Appen (APX), Afterpay (APT), Advanced Micro Devices (AMD), Altium (ALU) and Alector (ALEC). This page (ASX:NXS) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersAI “wealth window” is closing June 25thParadigm PressThe asset beating inflation by 4xColonial MetalsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Next Science Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
